Chuang F M, West B L, Baxter J D, Schaufele F
Metabolic Research Unit, University of California, San Francisco 94143-0540, USA.
Mol Endocrinol. 1997 Aug;11(9):1332-41. doi: 10.1210/mend.11.9.9978.
Pituitary-specific transcription of the evolutionarily related rat (r) GH and PRL genes involves synergistic interactions between Pit-1 and other promoter-binding factors including nuclear receptors. We show that Pit-1/thyroid hormone receptor (TR) and Pit-1/estrogen receptor (ER) synergistic activation of the rGH and rPRL promoters are globally similar. Both synergies depend upon the same activation functions in Pit-1 and also require activation function-2 conserved in TR and ER. The activation function-2 binding protein, RIP140, previously thought to be a nuclear receptor coactivator, strongly inhibits both Pit-1/TR and Pit-1/ER synergy. RIP140 inhibition is profoundly influenced, in a promoter-specific fashion, by a synergism-selective function in Pit-1: deletion of Pit-1 amino acids 72-100 switches RIP140 to an activator of Pit-1/ER and Pit-1/TR synergy at the rPRL promoter but not at the rGH promoter. Pit-1 amino acids 101-125 are required for RIP140 inhibition or activation again only at the rPRL promoter. Therefore, functions within one factor can determine the activity of a coactivator binding to its synergistic partner. This promoter context-specific synergistic interplay between transcription factors and coactivators is likely an essential determinant of cell-specific transcriptional regulation.
进化相关的大鼠(r)生长激素(GH)和催乳素(PRL)基因的垂体特异性转录涉及Pit-1与其他启动子结合因子(包括核受体)之间的协同相互作用。我们发现,Pit-1/甲状腺激素受体(TR)和Pit-1/雌激素受体(ER)对rGH和rPRL启动子的协同激活在总体上是相似的。这两种协同作用都依赖于Pit-1中相同的激活功能,并且还需要TR和ER中保守的激活功能-2。激活功能-2结合蛋白RIP140,以前被认为是一种核受体共激活因子,强烈抑制Pit-1/TR和Pit-1/ER的协同作用。RIP140的抑制作用以启动子特异性方式受到Pit-1中一种协同作用选择性功能的深刻影响:删除Pit-1的72-100位氨基酸会使RIP140在rPRL启动子处转变为Pit-1/ER和Pit-1/TR协同作用的激活剂,但在rGH启动子处则不然。Pit-1的101-125位氨基酸对于RIP140的抑制或激活作用同样仅在rPRL启动子处是必需的。因此,一个因子内的功能可以决定与其协同伙伴结合的共激活因子的活性。转录因子和共激活因子之间这种启动子背景特异性的协同相互作用可能是细胞特异性转录调控的一个重要决定因素。